UNSPSC 51122603: Ezetimibe/simvastatin

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class CV350. This VA Drug Class (CV350) classifies this compound as belonging to the group ANTILIPEMIC AGENTS.

UNSPSC 51122603 Ezetimibe/simvastatin is a Commodity code that reflects pharmaceutical supply procurement, though state and local governments are buying a much broader class of emergency medications under this code than the narrow chemical name suggests. Recent solicitation activity shows jurisdictions purchasing advanced life support medications including vasopressors, antiarrhythmics, and other injectable drugs for emergency medical services and fire rescue operations, not cholesterol-management pharmaceuticals. Fire rescue departments and emergency medical services represent the primary end-users, with procurement managed through municipal purchasing offices. The scope includes firm pricing with all costs embedded (shipping, freight, and applicable taxes), strict expiration-date requirements (typically nine months or more from acceptance), rapid delivery windows (often within ten days of order), and comprehensive compliance documentation including Safety Data Sheets and OSHA Hazard Communication Standards certifications. Vendors are expected to warrant products against defects and to manage expired-material replacement and pickup before the contract expiration date.

The City of Tampa Fire Rescue issued an IFB (Bid No. 26P00188) for Advanced Life Support Medications on April 24, 2026, with a response deadline of April 8, 2026, and an estimated contract value of $40,000.00. The bid sought four specific medication line items totaling approximately 3,530 units and included a Small Local Business Enterprise sheltered market designation offering a 5 percent bid discount for SLBE participation, not to exceed $10,000. The contract term was structured as one year from award with two one-year renewal options and the city's unilateral right to extend for up to three additional 30-day periods. Recent activity centers in Florida; the source does not support characterization of activity in other states or broader geographic spread.